risks of tirzepatide and Cancer Risk in Individuals with and without Diabetes: A Systematic Review and Meta-Analysis Cardiovascular outcomes of semaglutide and

Plus a daily research insight email from the lab

PLoS One 19 , e0308905 (2024)

Call the pharmacy that dispensed your semaglutide and describe the appearance issue in detail

Key Takeaway: If your prescription label lists Semaglutide/Cyanocobalamin or Semaglutide/B12, the red color is a normal and expected result of the vitamins natural pigmentation

It depends on the patient

Therefore increased monitoring of valproate and concomitant drug concentrations and dosage adjustment are indicated whenever enzyme-inducing or inhibiting drugs are introduced or withdrawn (7.1) Aspirin, carbapenem antibiotics, estrogen-containing hormonal contraceptives: Monitoring of valproate concentrations is recommended (7.1) Co-administration of valproate can affect the pharmacokinetics of other drugs (e.g., diazepam, ethosuximide, lamotrigine, phenytoin) by inhibiting their metabolism or protein binding displacement (7.2) Patients stabilized on rufinamide should begin valproate therapy at a low dose, and titrate to clinically effective dose (7.2) Dosage adjustment of amitriptyline/nortriptyline, propofol, warfarin, and zidovudine may be necessary if used concomitantly with Valproic acid (7.2) Topiramate: Hyperammonemia and encephalopathy (5.10, 7.3) Use In Specific Populations Pregnancy: Valproic acid can cause congenital malformations including neural tube defects, decreased IQ, and neurodevelopmental disorders (5.2, 5.3, 8.1) Pediatric: Children under the age of two years are at considerably higher risk of fatal hepatotoxicity (5.1, 8.4) Geriatric: Reduce starting dose